Associations of Empagliflozin With Left Ventricular Volumes, Mass, and Function in Patients With Heart Failure and Reduced Ejection Fraction

医学 射血分数 恩帕吉菲 心脏病学 内科学 心力衰竭 安慰剂 心室重构 糖尿病 2型糖尿病 内分泌学 病理 替代医学
作者
Massar Omar,J. Steen Jensen,Mulham Ali,Peter Frederiksen,Caroline Kistorp,Lars Videbæk,Mikael Kjær Poulsen,Christian Tuxen,Søren Møller,Finn Gustafsson,Lars Køber,Morten Schou,Jacob Eifer Møller
出处
期刊:JAMA Cardiology [American Medical Association]
卷期号:6 (7): 836-836 被引量:136
标识
DOI:10.1001/jamacardio.2020.6827
摘要

Sodium-glucose cotransporter-2 inhibitors (SGLT2i) improve outcomes in patients with heart failure and a reduced ejection fraction (HFrEF). The association with cardiac remodeling has not been investigated.To investigate the outcome of the SGLT2i empagliflozin, compared with placebo, on cardiac remodeling in patients with HFrEF.This exploratory post hoc analysis included participants with stable HFrEF and ejection fractions of 40% or less, who were randomly enrolled in an investigator-initiated, multicenter, double-blind, placebo-controlled randomized clinical trial in Denmark. Enrollment commenced on June 29, 2017, and continued through September 10, 2019, with the last participant follow-up on December 20, 2019.Randomization (1:1) to empagliflozin (10 mg once daily) or matching placebo in addition to recommended heart failure therapy for 12 weeks.Efficacy measures were changes from baseline to week 12 in left ventricular end-systolic and end-diastolic volume indexes, left atrial volume index, and left ventricular ejection fraction adjusted for age, sex, type 2 diabetes, and atrial fibrillation. Secondary efficacy measures included changes in left ventricular mass index, global longitudinal strain, and relative wall thickness.A total of 190 patients were randomized (95 each receiving empagliflozin and placebo), with a mean (SD) age of 64 (11) years; 162 were men (85.3%), 97 (51.1%) had ischemic HFrEF, 24 (12.6%) had type 2 diabetes, and the mean (SD) latest recorded left ventricular ejection fraction was 29% (8%). Of the 190, 186 completed the study. Empagliflozin significantly reduced left ventricular end-systolic volume index (-4.3 [95% CI, -8.5 to -0.1] mL/m2; P = .04), left ventricular end-diastolic volume index (-5.5 [95% CI, -10.6 to -0.4] mL/m2; P = .03), and left atrial volume index (-2.5 [95% CI, -4.8 to -0.1] mL/m2; P = .04) compared with placebo at 12 weeks' follow-up, with no change in left ventricular ejection fraction (1.2% [95% CI, -1.2% to 3.6%]; P = .32). These findings were consistent across subgroups. Of secondary efficacy measures, left ventricular mass index was significantly reduced by empagliflozin (-9.0 [95% CI, -17.2 to -0.8] g/m2; P = .03).In this small, randomized, short-term study, empagliflozin was associated with modest reductions in left ventricular and left atrial volumes with no association with ejection fraction. Effects beyond 12 weeks of SGLT2i use require further study.ClinicalTrials.gov Identifier: NCT03198585.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
qqq完成签到,获得积分10
刚刚
gewenxue发布了新的文献求助10
1秒前
3秒前
共享精神应助猪猪hero采纳,获得10
3秒前
4秒前
4秒前
Sunrise发布了新的文献求助10
5秒前
PSL完成签到,获得积分10
5秒前
5秒前
6秒前
7秒前
liuyf完成签到 ,获得积分10
7秒前
9秒前
9秒前
YJ888发布了新的文献求助10
9秒前
今后应助Lu采纳,获得10
9秒前
EED发布了新的文献求助10
9秒前
88C真是太神奇啦完成签到,获得积分10
10秒前
10秒前
Rondab应助shuyi采纳,获得30
11秒前
酷酷飞烟发布了新的文献求助10
12秒前
13秒前
在水一方应助故意的靳采纳,获得50
14秒前
16秒前
忧郁的鱿鱼完成签到,获得积分10
16秒前
JamesPei应助lm采纳,获得10
18秒前
xww完成签到,获得积分10
18秒前
隐形曼青应助忐忑的阑香采纳,获得10
19秒前
秋半梦发布了新的文献求助10
20秒前
slp完成签到,获得积分20
27秒前
秋半梦完成签到,获得积分10
30秒前
bububusbu完成签到,获得积分10
30秒前
量子星尘发布了新的文献求助10
31秒前
我是老大应助TTm采纳,获得20
32秒前
科研通AI5应助Bressanone采纳,获得10
32秒前
坡坡大王发布了新的文献求助10
33秒前
华仔应助anna采纳,获得10
37秒前
carlin完成签到,获得积分10
39秒前
白子双完成签到,获得积分10
43秒前
FXQ123_范完成签到,获得积分10
43秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3989115
求助须知:如何正确求助?哪些是违规求助? 3531367
关于积分的说明 11253688
捐赠科研通 3269986
什么是DOI,文献DOI怎么找? 1804868
邀请新用户注册赠送积分活动 882078
科研通“疑难数据库(出版商)”最低求助积分说明 809105